Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Canadian Weed Producer Reduces Net Loss For 2023 But Reports Higher Debt

Author: Nina Zdinjak | April 30, 2024 08:33am

Canadian marijuana company Red White & Bloom Brands Inc. (CSE:RWB) (OTC:RWBYF) reported its financial results Monday for the fourth quarter and fiscal year 2023, revealing quarterly revenue of CA$19.9 million ($14.5 million), compared to CA$15.4 million in the same period of 2022. For the fiscal year 2023, the Toronto-based operator reported revenues of CA$88.3 million, compared to CA$87.7 million in fiscal 2022.  

"RWB continued to effect value-added transformations of its business during fiscal 2023," stated Colby De Zen, president and director. "We focused on higher margin revenue opportunities and sunsetting of low margin products, as can be seen in our results, which has led to a 30% increase in gross margin with revenue only increasing marginally over the same period. Moving into fiscal 2024, the company has targeted several near-term priorities, including a fulsome restructuring of its current financing arrangements, resourcing its key business segments, both in Canada and across incumbent and prospective US states, providing a path for our company and its valued team members to achieve profitable growth and sustainable liquidity."  

Grow your cannabis business and raise capital at Benzinga’s New Jersey Market Spotlight on June 17. Network with key industry players, hear from the top operators and close deals that will shape the future. Act now— spots are filling fast. Get your tickets here

Q4 2023 Results Compared To Q4 2022

  • Gross profit was CA$7.4 million, compared to CA$1.3 million. 
  • Net loss amounted to CA$118.1 million, versus net loss of CA$206.1 million. 
  • Adjusted EBITDA was a gain of CA$1.7 million, compared to an Adjusted EBITDA loss of CA$3.2 million. 

FY 2023 Results Compared To FY 2022 

  • Gross profit was CA$31.2 million, which compares to CA$22.5 million. 
  • Adjusted EBITDA was a gain of CA$5.5 million, versus CA$7.2 million. 
  • Operating expenses were CA$11.0 million, compared to CA$7.4 million.
  • Net loss amounted to CA$143.6 million, which compares to a net loss of CA$242.1 million. 
  • At the end of 2023, the company had reported a debt of CA$240 million, compared to a debt of CA$171.8 million at the end of 2022. 

Related Links: 

4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge – Who Will Lead? Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & LosersToronto Weed Producer Seals Deal For Over $100M In Annual Revenue As RWB Finalizes Aleafia Health Buyout

Photo: Courtesy of Ryland zweifel via Shutterstock

Posted In: CSE:RWB RWBYF